Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets.

Mima A.

J Diabetes Res. 2013;2013:248563. doi: 10.1155/2013/248563. Epub 2013 Jun 3. Review.

2.

Combination of aspirin with telmisartan suppresses the augmented TGFbeta/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy.

Mulay SR, Gaikwad AB, Tikoo K.

Chem Biol Interact. 2010 Apr 29;185(2):137-42. doi: 10.1016/j.cbi.2010.03.008. Epub 2010 Mar 9.

PMID:
20223228
3.

Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.

Elmarakby AA, Sullivan JC.

Cardiovasc Ther. 2012 Feb;30(1):49-59. doi: 10.1111/j.1755-5922.2010.00218.x. Epub 2010 Aug 16. Review.

PMID:
20718759
4.

Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives.

Lv M, Chen Z, Hu G, Li Q.

Drug Discov Today. 2015 Mar;20(3):332-46. doi: 10.1016/j.drudis.2014.10.007. Epub 2014 Oct 31. Review.

PMID:
25448752
5.

Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.

Zhang H, Saha J, Byun J, Schin M, Lorenz M, Kennedy RT, Kretzler M, Feldman EL, Pennathur S, Brosius FC 3rd.

Am J Physiol Renal Physiol. 2008 Oct;295(4):F1071-81. doi: 10.1152/ajprenal.90208.2008. Epub 2008 Jul 30.

6.

A review of oxidative stress related genes and new antioxidant therapy in diabetic nephropathy.

Makuc J, Petrovič D.

Cardiovasc Hematol Agents Med Chem. 2011 Oct;9(4):253-61. Review.

PMID:
21902657
7.

Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress.

Zhang M, Hagiwara S, Matsumoto M, Gu L, Tanimoto M, Nakamura S, Kaneko S, Gohda T, Qian J, Horikoshi S, Tomino Y.

Metabolism. 2006 Dec;55(12):1590-8.

PMID:
17142129
8.

Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.

Alhaider AA, Korashy HM, Sayed-Ahmed MM, Mobark M, Kfoury H, Mansour MA.

Chem Biol Interact. 2011 Jul 15;192(3):233-42. doi: 10.1016/j.cbi.2011.03.014. Epub 2011 Mar 30.

PMID:
21457706
9.

Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase.

Chang CC, Chang CY, Wu YT, Huang JP, Yen TH, Hung LM.

J Biomed Sci. 2011 Jun 23;18(1):47. doi: 10.1186/1423-0127-18-47.

10.

Role of inflammation in diabetic nephropathy.

Fornoni A, Ijaz A, Tejada T, Lenz O.

Curr Diabetes Rev. 2008 Feb;4(1):10-7. Review.

PMID:
18220690
11.

Diabetic nephropathy: causes and managements.

Tripathi YB, Yadav D.

Recent Pat Endocr Metab Immune Drug Discov. 2013 Jan;7(1):57-64. Review.

PMID:
23227864
12.

Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation.

Luo ZF, Feng B, Mu J, Qi W, Zeng W, Guo YH, Pang Q, Ye ZL, Liu L, Yuan FH.

Toxicol Appl Pharmacol. 2010 Jul;246(1-2):49-57. doi: 10.1016/j.taap.2010.04.005. Epub 2010 Apr 24.

PMID:
20399799
14.

Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy.

Agarwal R.

Am J Physiol Renal Physiol. 2006 Mar;290(3):F600-5. Epub 2005 Sep 13.

15.

[Mechanism of Chinese herbal medicine delaying glomerulosclerosis in diabetic nephropathy].

Chen J, Wan Y, Bian R, Gu L, Wang C, Zhang H, Yao J.

Zhongguo Zhong Yao Za Zhi. 2010 Feb;35(4):525-30. Review. Chinese.

PMID:
20450059
16.

The role of inflammatory cytokines in diabetic nephropathy.

Navarro-González JF, Mora-Fernández C.

J Am Soc Nephrol. 2008 Mar;19(3):433-42. doi: 10.1681/ASN.2007091048. Epub 2008 Feb 6. Review.

17.

Oxidative stress and antioxidant treatment in diabetes.

Scott JA, King GL.

Ann N Y Acad Sci. 2004 Dec;1031:204-13. Review.

PMID:
15753146
18.

Inhibition of inflammation by pentosan polysulfate impedes the development and progression of severe diabetic nephropathy in aging C57B6 mice.

Wu J, Guan TJ, Zheng S, Grosjean F, Liu W, Xiong H, Gordon R, Vlassara H, Striker GE, Zheng F.

Lab Invest. 2011 Oct;91(10):1459-71. doi: 10.1038/labinvest.2011.93. Epub 2011 Aug 1.

19.

Ferulsinaic acid attenuation of diabetic nephropathy.

Sayed AA.

Eur J Clin Invest. 2013 Jan;43(1):56-63. doi: 10.1111/eci.12015. Epub 2012 Nov 28.

PMID:
23190272
20.

Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes.

Mima A, Qi W, Hiraoka-Yamomoto J, Park K, Matsumoto M, Kitada M, Li Q, Mizutani K, Yu E, Shimada T, Lee J, Shoelson SE, Jobin C, Rask-Madsen C, King GL.

Invest Ophthalmol Vis Sci. 2012 Dec 19;53(13):8424-32. doi: 10.1167/iovs.12-10207.

Supplemental Content

Support Center